Q1 2022 Panbela Therapeutics Inc Earnings Call Transcript
Good afternoon, ladies and gentlemen. Thank you for standing by. Welcome to the Panbela Therapeutics' first-quarter 2022 earnings call. At this time, all participants are in a listen-only mode.
After management's prepared remarks, there will be a question-and-answer session. I would now like to turn the call over to the host, James Carbonara, Investor Relations at Hayden. Please go ahead.
Thank you. And once again, welcome to Panbela's first-quarter 2022 earnings call. With me on the call are Jennifer Simpson, Chief Executive Officer; and Sue Horvath, Chief Financial Officer.
Before I turn the call over to Dr. Simpson, please note that statements made on this call that are not historical facts may be forward-looking statements. Significant risks and uncertainties that could cause actual results to differ from those expressed or implied in the forward-looking statements are detailed in the company's annual report on Form 10-K and supplemented by subsequently filed quarterly reports on Form 10-Q as well as in other
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |